Estrogens and Alzheimer's disease;Oestrogenes et maladie d'Alzheimer

Angeiologie

Volumn 51, Issue 1, 1999, Pages 34-44

  Bentue Ferrer, Danièle ^a   Reymann, Jean Michel ^a   Allain, Hervé ^a  

^a Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GALANTAMINE; HEPTYLSTIGMINE TARTRATE; METRIFONATE; NERVE GROWTH FACTOR; PHYSOSTIGMINE;

ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CHOLINESTERASE INHIBITION; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; NEUROPROTECTION; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 0033000230     PISSN: 00033049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. CUMMINGS JL, VINTERS HV, COLE GM, KHACHATURIAN ZS : Alzheimer's disease. Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998, 51 (suppl 1), S2-S17.
2. SELKOE DJ, YAMAZAKI T, CITRON M, PODLISNY MB, KOO EH, TEPLOW DB, HAASS C : The role of APP processing and trafficking pathways in the formation of amyloid β-protein. Ann NY Acad Sci, 1996, 777, 57-64.
3. NEVE RL, ROBAKIS NK : Alzheimer's disease : a re-examination of the amyloid hypothesis. Trends Neurosci 1998, 21, 15-19.
4. LEE VM : Regulation of tau phosphorylation in Alzheimer's disease. Ann NY Acad Sci 1996, 777, 121-131.
5. LOVESTONE S, REYNOLDS CH : The phosphorylation of tau : a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997, 78, 309-324.
6. FARLOW MR, EVANS RM : Pharmacologic treatment of cognition in Alzheimer's dementia. Neurology 1998, 51 (suppl 1), S36-S44.
7. BRINTON RD, YAMAZAKI RS : Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharm Res 1998, 15, 386-398.
8. GRUNDMAN M, COREY-BLOOM J, THAL LJ : Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. J Neural Transm 1998, suppl 53, 255-275.
9. ALLAIN H, BENTUÉ-FERRER D, BELLIARD S, DEROUESNÉ C : Pharmacology of Alzheimer's disease. In : Progress in Medicinal Chemistry, GP ellis, DK Luscombe eds, Elsevier, Amsterdam, Lausanne, New-York, Oxford, Shannon, Tokio, 1997, 34, 1-67.
10. ALLAIN H, BENTUÉ-FERRER D, ZEKRI O, SCHUCK S, LEBRETON S, REYMANN JM : Experimental and clinical methods in the development of anti-Alzheimer drugs. Fundam Clin Pharmacol 1998, 12, 13-29.
11. PESKIND ER : Pharmacologic approaches to cognitive deficits in Alzheimer's disease. J Clin Psychiatry 1998, 59 (Suppl 9), 22-27.
12. HERMANN N, LANCTOT KL, NARAN JOCA : Behavioural disorders in demented elderly patients. Current issues in pharmacotherapy. CNS Drugs 1996, 6, 280-300.
13. CHOI BH : Oxidative stress and Alzheimer's disease. Neurobiol Aging 1995, 16, 675-678.
14. CONNOR B, DRAGUNOW M : The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 1998, 27, 1-39.
15. KRIEGLSTEIN J : Excitotoxicity and neuroprotection. Eur J Pharmaceut Sci 1997, 5, 181-187.
16. MATTSON MP, RYDEL RE, LIEBERBURG I, SMITH-SWISTOSKY VL : Altered calcium signaling and neuronal injury : stroke and Alzhermer's disease as examples. Ann NY Acad Sci 1993, 679, 1-21.
17. KAWAS C, RESNICK S, MORISSON A et al. : A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997, 48, 1517-1521.
18. RESNICK SM, METTER EI, ZONDERMAN AB : Estrogen replacement therapy and longitudinal decline in visual memory. Neurology 1997, 49, 1491-1497.
19. TANG MX, JACOBS D, STERN Y et al. : Effect of œsirogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348, 429-432.
20. BALDERESCHI M, DI CARLO A, LEPORE V et al. : Estrogenreplacement therapy and Alzheimer's disease in the Italian longitudinal study on aging. Neurology 1998, 50, 996-1002.
21. YAFFE K, SAWAYA G, LIEBERBURG I, GRADY D : Estrogen therapy in postmenopausal women. JAMA 1998, 279, 688-695.
22. BARRETT-CONNOR E, KRITZ-SILVERSTEIN D : Estrogen replacement therapy and cognitive function in older women. JAMA 1993, 269, 2637-2641.
23. HEYMAN A, WILKINSON WE, STAFFORD JA et al. : Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984, 15, 335-41.
24. AMADUCCI LA, FRATIGLIONI L, ROCCA WA et al. : Risk factors in clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986, 36, 922-931.
25. BROE GA, HENDERSON AS, CREASEY H et al. : A case-control study of Alzheimer's disease in Australia. Neurology 1990, 40, 1698-1707.
26. GRAVES AB, WHITE E, KOEPSELL TD et al. : A case-control study of Alzheimer's disease. Ann Neurol 1990, 28, 766-774.
27. HENDERSON VW, PAGANINI-HILL A, EMANUEL CK, DUNN ME, BUCKWALTER JG : Estrogen replacement therapy in older women : comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994, 51, 896-900.
28. BRENNER DE, KUKULL WA, STERGACHIS A et al. : Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease : a population-based case-control study. Am J Epidemiol 1994, 140, 262-267.
29. MORTEL KF, MEYER JS : Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatr Clin Neurosci 1995, 7, 334-337.
30. VAN DUIJN CM, MEIJER H, WITTEMAN JCM el al. : Estrogen, apolipoprotein E and the risk of Alzheimer's disease. Neurobiol Aging 1996, 17 (suppl 4S), S79-S80.
31. LERNER A, KOSS E, DEBANNE S, ROWLAND D, SMYTH K, FRIEOLAND R. Smoking and œtrogen-replacement therapy as protective factors for Alzheimer's disease. Lancet 1997, 349, 403-404.
32. PAGANINI-HILL A, HENDERSON VW : Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140, 256-261.
33. HENDERSON VW : Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 1997, 8, 343-351.
34. SCHNEIDER LS, FINCH CE : Can estrogens prevent neurodegeneration? Drugs Aging 1997, 11, 87-95.
35. FILLIT H, WEINREB H, CHOLST I, LUINE V, MC EWEN B, AMADOR R, ZABRISKIE J : observations in preliminary open trial of œstradiol therapy for senile dementia, Alzheimer's type. Psychoneuroendocrinology 1986, 11, 337-345.
36. HONJO H, OGINO Y, NAITGH K et al. : In vivo effects of estrone sulfate on the central nervous system : senile dementia (Alzheimer's type). J Steroid Biochem 1989, 34, 521-525.
37. HONJO H, OGINO Y, TANAKA K et al. : An effect of conjugated estrogen on cognitive impairment in women with senile dementia : Alzheimer's type : a placebo-controlled, doubleblind study. J Japan Menopause Soc 1993, 1, 167-171.
38. OHKURA T, ISSE K, AKAZAWA K et al. : An open trial of estrogen therapy for dementia of the Alzheimer type in women. In: Berg G, Hammar M, editors. The modern management of the menopause: a perspective for the 21st century. Carnforth: Parthenon 1994, 315-333.
39. OHKURA T, ISSE K, AKAZAWA K, HAMAMOTO M, YAOI Y, HAGINO N : Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine J 1994, 41, 361-371.
40. OHKURA T, ISSE K, AKAZAWA K et al. : Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1994, 1 : 125-130.
41. FILLIT H : Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women. Ann N Y Acad Sci 1994, 743, 233-238.
42. OHKURA T, ISSE K, AKAZAWA K, HAMAMOTO M, YAOI Y, HAGINO N : Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995, 6, 99-107.
43. BIRGE SJ : The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997, 48 (suppl 7), S36-S41.
44. ASTHANA S, CRAFT S, BAKER LD et al. : Transdermal estrogen improves memory in women with Alzheimer's disease. Soc Neurosci Abstr 1996, 22, 200 (abstract).
45. WEISS BL : Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. Am J Psychiatry 1987, 144, 386-387.
46. SKOLNICK AA : Evaluating estrogen for Alzheimer disease poses ethical and logistical challenges. JAMA 1997, 277, 1831-1833.
47. CALDWELL B, WATSON R : An evaluation of psychologic effects of sex hormone administration in aged women: results after six months. J Gerontol 1952, 7, 228-244.
48. KANTOR HI, MICHAEL CM, SHORE H : Estrogen for older women. Am J Obstet Gynecol 1973, 116, 115-118.
49. RAURAMO L, LAGERSPETZ K, ENGBLOSI P, PUNNONEN R : The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res 1975, 3, 94-104.
50. HACKMAN BW, GAI BRAITH D : Replacement therapy and piperazine œstrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin 1976, 4, 303-106.
51. CAMPBELL S, WHITEHEAD M : (Estrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977, 4, 31-47.
52. FEDOR-FREYBERGH P : The influence of œstrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl 1977, 64, 1-91.
53. SHERWIN BB : Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13, 345-357.
54. DITKOFF EC, CRARY WG, CRISTO M, LOBO RA : Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991, 78, 991-995.
55. PHILLIPS SM SHERWIN BB : Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology, 1992, 17, 485-495.
56. POLO-KANTOLA P, PORIN R, POLO O, HELENUS H, IRJALA K, ERKKOLA R : The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998, 91, 459-466.
57. HENDERSON VW : Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med 1997, 103, 11S-18S
58. SCHNEIDER LS, FARLOW MR, HENDERSON VW, POGODA JM : Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996, 46, 1580-1584.
59. SOHRABJI F, MIRANDA RC : Hormone replacement : therapeutic strategies in the treatment of Alzheimer's disease and ageing-related cognitive disorders. Exp Opin Ther Patents 1997, 7, 611-629.
60. MCMILLAN PJ, SINGER CA, DORSA DM : The effects of ovariectomy and estrogen replacement on trk A and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J Neurosci 1996, 16, 1860-1865.
61. GIBBS RB : Impairment of basal forebram cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol 1998, 151, 289-302.
62. GIBBS RB : Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann NY Acad Sci 1994, 743, 165-199.
63. GREEN P, GRIDLEY K, SIMPKINS J : Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 1996, 218, 165-168.
64. MOOK-JUNG I, JOO I, SOHN S, KWON HJ, HUH K, JUNG MW : Estrogen blocks neurotoxic effects of β-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci Lett 1997, 235, 101-104.
65. JAFFE A, TORAN-ALLERAND CD, GREENGARD P, GANDY S : Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994, 269, 13065-13068.
66. XU H, Gouras GK, Greenfield JP et al. : Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 1998, 4, 447-451.
67. MILLER DB, ALI SF, O'CALLAGHAN JP, LAWS SC : The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998, 844, 153-165.
68. REGAN RF, GUO Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 1997, 764, 133-140.
69. BEJIL C, WIDMANN M, TRAPP T, HOLSBOER F : 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995, 216, 473-482.
70. GOODMAN Y, BRUCE AJ, CHENG B, MATTSON MP : Estrogens attenuate and corticosterone exacerbates excitotoxicity. oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996, 66, 1836-1844.
71. BRINTON RD, PROFFITT P, TRAN J, LUU R : Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of conical neurons via an NMDA receptor dependent mechanism. Exp Neurol 1997, 147, 211-220.
72. PRELEVIC GM, JACOBS HS : New developments in post menopausal hormone replacement therapy. Curr Opin. Obstet Gynecol 1997, 9, 207-212.
73. BIRGE SJ. Hormones and the aging brain. Genatrics 1998, 53 (suppl 1), 528-530